Form D · Pharmaceuticals
CHIMERIX INC
Durham, NC · CIK 0001117480
Offering snapshot reported Jul 31, 2019 · SEC filing
- Reported sold
- $34.9M Offering amount: $34.9M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 26, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 31, 2019 | Initial | $34,900,000 | No comparison | 1 | SEC filing |
| Feb 15, 2011 | Initial | $45,000,010 | No comparison | 21 | SEC filing |
| Aug 7, 2009 | Initial | $16,130,011 | No comparison | 21 | SEC filing |
| Mar 12, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-345516
Source: Form D, filed Jul 31, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Merrick Almond, Ph.D. | Executive |
| Michael A. Alrutz | Executive |
| Mike Andriole | Executive |
| Farah Champsi | Director |
| Graham K. Crooke, M.B.B.S. | Director |
| James M. Daly | Director |
| Martha J. Demski | Director |
| Catherine L. Gilliss | Director |
| Edward F. Greissing, Jr. | Director |
| Heather Knight Trent | Executive |
| Randall Lanier | Executive |
| Patrick Machado | Director |
| Robert J. Meyer | Director |
| Fred A. Middleton | Director |
| Kenneth I. Moch | Executive |
| Odin Naderer | Executive |
| W. Garrett Nichols | Executive |
| James Niedel | Director |
| Rosemary O'mahony, Ph.D. | Executive |
| Gwendolyn P. Painter, M.D., Mph | Executive |
| George Painter, Ph.D | Director, Executive |
| George Painter, Ph.D. | Director, Executive |
| Arthur M. Pappas | Director |
| Edward E. Penhoet, Ph.D. | Director |
| Ronald C. Renaud, Jr | Director |
| Seth A. Rudnick, M.D. | Director |
| Mike Sherman | Director, Executive |
| Roy W. Ware | Executive |
| Timothy J. Wollaeger | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2505 Meridian Parkway, Suite 100
Durham, NC, 27713
Durham, NC, 27713